Key Innovations from the Lab

  • Magnetic Blood Purification - for the treatment of sepsis (now translated by Hemotune - first in man 2024)
  • AnastoSeal - first-of-its-kind surgical sealant and ultrasound-based detection of complications deep inside the body (now translated by Veltist)
  • SensAL - naked-eye sensor for the detection of post-operative complications
  • NanoGlue - Nanoparticle-based tissue glue actively supporting the different phases of wound healing and countering wound infections (now translated by Anavo Medical)
  • PreXision - radiocatalytically active inorganic oxide nanoparticles for radio- and proton therapy augmentation
  • iSoldering - intelligent laser tissue soldering enabling seamless tissue fusion in open as well as endoscopic/robotic surgery
  • MenstruAI - non-invasive health monitoring based on menstruation blood (now translated by MenstruAI)
  • EndoStop - First-of-its-kind endometriosis treatment

Spin-Offs

- Hemotune

- Anavo Medical (CEO: Dr Tino Matter)

- Veltist (CEO: Dr Alex Anthis)

- MenstruAI 

Patents and Patent Applications

P1         A.H.C Anthis, I.K. Herrmann, EPXXXXXXXX.

P2         A.H.C Anthis, I.K. Herrmann, T. Rduch, S. Kilchenmann, EP24167147.

P3         H.J. Hug, E. Mayr, I.K. Herrmann, Tracer particles, EP 24163001.

P4         L. Dosnon, I.K. Herrmann, A device for detection of biomarkers, EP23209241.

P5         A. Jessernig, A. Anthis, I.K. Herrmann,  Biosensor, EP23178489.3.

P6         O. Cipolato, I.K. Herrmann, Composition for Laser Tissue Soldering, EP21216014.7.

P7         M.T. Matter, I.K. Herrmann, Nanoparticle Compositions, PCT/EP21168502.

P8         A. Anthis, B. Suter, I.K. Herrmann, Patch comprising sensing components, PCT/EP2022/051141.

P9         A. Anthis, M.T. Matter, I.K. Herrmann, Kit comprising adhesive hydrogel and impregnating fluid, PCT/EP2022/051137.

P10        M.T. Matter, I.K. Herrmann, S.E. Pratsinis, Coatings, Coated Implants And Manufacturing Methods Therefore. PCT/EP19216118. 

P11        L. Limbach, I.K. Herrmann, W.J. Stark, B. Beck-Schimmer, M. Urner, Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia reperfusion event, PCT/EP2010/004582, WO/2011/012283.